NFKB1 and diffuse large B-cell lymphoma: We also identified crosstalk between non-canonical and canonical NF-κB activity, which results in distinct induction of BC2-family proteins and enables canonical NF-κB inhibition to also resensitize these DLBCL cells in the context of TME-mediated BH3-mimetic resistance.